Orloff M - Search Results

1

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma.

Minor DR, Kim KB, Tong RT, Wu MC, Kashani-Sabet M, Orloff M, Eschelman DJ, Gonsalves CF, Adamo RD, Anne PR, Luke JJ, Char D, Sato T. Minor DR, et al. Among authors: orloff m. Cancer Biother Radiopharm. 2022 Feb;37(1):11-16. doi: 10.1089/cbr.2021.0366. Epub 2022 Jan 12. Cancer Biother Radiopharm. 2022. PMID: 35021863 Free PMC article. Clinical Trial.

2

Successes and setbacks of early investigational drugs for melanoma.

Orloff M, Valsecchi ME, Sato T. Orloff M, et al. Expert Opin Investig Drugs. 2015;24(8):993-7. doi: 10.1517/13543784.2015.1051618. Epub 2015 Jun 12. Expert Opin Investig Drugs. 2015. PMID: 26068553

3

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.

Terai M, Mu Z, Eschelman DJ, Gonsalves CF, Kageyama K, Chervoneva I, Orloff M, Weight R, Mastrangelo MJ, Cristofanilli M, Sato T. Terai M, et al. Among authors: orloff m. EBioMedicine. 2015 Sep 18;2(11):1821-6. doi: 10.1016/j.ebiom.2015.09.019. eCollection 2015 Nov. EBioMedicine. 2015. PMID: 26870807 Free PMC article.

4

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Orloff M, Weight R, Valsecchi ME, Sato T. Orloff M, et al. Rev Recent Clin Trials. 2016;11(2):81-6. doi: 10.2174/1574887111666160330120712. Rev Recent Clin Trials. 2016. PMID: 27028970

5

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.

Valsecchi ME, Orloff M, Sato R, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T. Valsecchi ME, et al. Among authors: orloff m. Ophthalmology. 2018 Feb;125(2):210-217. doi: 10.1016/j.ophtha.2017.08.017. Epub 2017 Sep 19. Ophthalmology. 2018. PMID: 28935400

6

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.

Javed A, Arguello D, Johnston C, Gatalica Z, Terai M, Weight RM, Orloff M, Mastrangelo MJ, Sato T. Javed A, et al. Among authors: orloff m. Immunotherapy. 2017 Dec;9(16):1323-1330. doi: 10.2217/imt-2017-0066. Immunotherapy. 2017. PMID: 29185395

7

Melanoma Immunotherapy in the Elderly.

Orloff M. Orloff M. Curr Oncol Rep. 2018 Mar 2;20(2):20. doi: 10.1007/s11912-018-0656-3. Curr Oncol Rep. 2018. PMID: 29500787 Review.

8

CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects.

Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. Dalvin LA, et al. Among authors: orloff m. Retina. 2018 Jun;38(6):1063-1078. doi: 10.1097/IAE.0000000000002181. Retina. 2018. PMID: 29689030 Review.

9

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma.

Chua V, Orloff M, Teh JL, Sugase T, Liao C, Purwin TJ, Lam BQ, Terai M, Ambrosini G, Carvajal RD, Schwartz G, Sato T, Aplin AE. Chua V, et al. Among authors: orloff m. EMBO Mol Med. 2019 Feb;11(2):e9081. doi: 10.15252/emmm.201809081. EMBO Mol Med. 2019. PMID: 30610113 Free PMC article.

10

A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.

Gonsalves CF, Eschelman DJ, Adamo RD, Anne PR, Orloff MM, Terai M, Hage AN, Yi M, Chervoneva I, Sato T. Gonsalves CF, et al. Among authors: orloff mm. Radiology. 2019 Oct;293(1):223-231. doi: 10.1148/radiol.2019190199. Epub 2019 Aug 27. Radiology. 2019. PMID: 31453767 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters